Literature DB >> 1727383

Role of tamoxifen in the induction of hormone-independent rat mammary tumors.

K C Fendl1, S J Zimniski.   

Abstract

Using the dimethylbenzanthracene-induced rat mammary tumor model, we examined the appearance and growth of tumors in animals given tamoxifen (TAM) either coincident with dimethylbenzanthracene or after initial tumor formation. While fewer tumors arose after coadministration of antiestrogen and carcinogen and TAM treatment caused regression of most existing tumors, new tumors developed in the presence of TAM in both studies. Since none of these new tumors regressed following ovariectomy, all were classified as hormone independent. Furthermore, these independent tumors grew more rapidly than both control-dependent and independent tumors, resulting in a greater average volume. These data suggest that a more aggressive form of hormone-independent tumor appears during TAM treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727383

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors:  Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

2.  Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.

Authors:  Tae Jung Jang; Ho Guen Jung; Ki Hoon Jung; Min Ku O
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

3.  Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.

Authors:  K Szepeshazi; A V Schally; G Halmos; B Szoke; K Groot; A Nagy
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Effect of Crocin on Cell Cycle Regulators in N-Nitroso-N-Methylurea-Induced Breast Cancer in Rats.

Authors:  Mahboobeh Ashrafi; S Zahra Bathaie; Saeid Abroun; Mahshid Azizian
Journal:  DNA Cell Biol       Date:  2015-09-22       Impact factor: 3.311

5.  Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.

Authors:  Francesca Giusti; Silva Ottanelli; Laura Masi; Antonietta Amedei; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

6.  Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.

Authors:  S J Zimniski; M E Brandt; D F Covey; D Puett
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer.

Authors:  J Maenpaa; V Wiebe; S Koester; G Wurz; V Emshoff; R Seymour; P Sipila; M DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 8.  Flow cytometry: potential utility in monitoring drug effects in breast cancer.

Authors:  S K Koester; J U Maenpaa; V J Wiebe; W J Baker; G T Wurz; R C Seymour; R E Koehler; M W DeGregorio
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance.

Authors:  J Maenpaa; V Wiebe; G Wurz; S Koester; V Emshoff; R Seymour; M DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.